AKR Purba obtained his Medical Doctor in 2007 from the Faculty of Medicine, Universitas Airlangga. In 2010, he started his Master at Universitas Gadjah Mada, and finished it cum laude with research in drug-drug interactions. In 2012, he started his medical specialization in clinical pharmacology at Universitas Indonesia with an internship program at Cipto Mangunkusomo Hospital. In 2016, he conducted his Ph.D. at UMCG, University of Groningen, the Netherlands. His Ph.D. research focused on pharmacotherapy, pharmacoepidemiology and pharmacoeconomics of antibiotic treatments. The research was conducted under Groningen University Institute for Drug Exploration. After finalizing his Ph.D., he continues working as a lecturer and researcher at Faculty of Medicine, Universitas Airlangga. Also, he has been involving in the Drug and Therapeutics Committee (KFT) at Dr. Soetomo Hospital, Surabaya; and in the expert working on the Essential Medicine List for antibiotic prophylaxis in WHO, Geneva, Switzerland, since 2018.
